TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
KARD

Kardigan, Inc.

Healthcare · Biotechnology

14.80$ -0.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Kardigan, Inc. (KARD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 722 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KARD
Line item Q1 26 Q2 26
348 722
298 610
82 384
287 598
26 26
649 106
32 70
3.7 3.8
9.1 14
-301 616
-337 -453
62 93

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?